Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 74 of 1,261
  1. US 12171761

    Vilazodone inclusion complexes, compositions and preparation thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  2. US 12171864

    Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method

    SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  3. US 12171741

    2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  4. US 12173079

    Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

    Dyne Therapeutics, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  5. US 12171758

    Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto

    Neumora Therapeutics, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  6. US 12171786

    Use of mesenchymal stem cells for the treatment of inflammation

    The Regents of the University of California · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  7. US 12171785

    Pluripotent cells derived from bone marrow and methods for isolation

    Regents of the University of Minnesota · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  8. US 12171877

    Materials and methods for delivering compositions to selected tissues

    The Regents of the University of California · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  9. US 12171759

    Methods and uses for treating anhedonia

    Xenon Pharmaceuticals Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  10. US 12173288

    Oligonucleotide-ligand conjugates and process for their preparation

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  11. US 12171734

    Pathogenic bacteria

    Sporegen Limited · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  12. US 12171803

    Methods of CD40 and toll like receptor immune activation

    The Board of Regents of the University of Texas System · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  13. US 12171822

    Infectious plasmodium sporozoites grown in vitro

    Sanaria Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  14. US 12173086

    Alpha-v beta-6 integrin ligands and uses thereof

    Arrowhead Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  15. US 12171854

    Heterocyclic-dithiol click chemistry

    Northwestern University · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  16. US 12172994

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  17. US 12171777

    Methods of making a cyclic dinucleotide

    Takeda Pharmaceutical Company Limited · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  18. US 12171765

    Combination therapies using PRMT5 inhibitors for the treatment of cancer

    Mirati Therapeutics, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  19. US 12171760

    Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

    Corcept Therapeutics Incorporated · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  20. US 12173337

    Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  21. US 12173289

    Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  22. US 12173317

    Use of histone modifiers to reprogram effector T cells

    The Board of Regents of the University of Texas System · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  23. US 12173307

    Methods for the purification of viral vectors

    BIOVERATIV THERAPEUTICS INC. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  24. US 12171884

    Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery

    The Regents of the University of California · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.